NCT00243594View on ClinicalTrials.gov

Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

January 31, 2009

Conditions
Melanoma Stage III or IV
Interventions
BIOLOGICAL

Peptide-pulsed dendritic cells

peptide-pulsed dendritic cells

Trial Locations (1)

6500 HB

Radboud University Nijmegen Medical Centre, Nijmegen

All Listed Sponsors
collaborator

Dutch Cancer Society

OTHER

lead

Radboud University Medical Center

OTHER

NCT00243594 - Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection | Biotech Hunter | Biotech Hunter